Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 170.90%37.99B | ---- | ---- | ---- | 307.56%14.02B | ---- | ---- |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---- | 2.22%-1.19B | ---- | ---- | ---- | -3,282.76%-1.21B | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -10.96%1.21B | ---- | ---- | ---- | 136.94%1.36B | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -10.96%1.21B | ---- | ---- | ---- | 136.94%1.36B | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | 9.38%-3.97B | ---- | ---- | ---- | -502.08%-4.38B | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | 9.38%-3.97B | ---- | ---- | ---- | -502.08%-4.38B | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | 56.48%-107.41M | ---- | ---- | ---- | 12.95%-246.83M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 309.31%199.48M | ---- | ---- | ---- | 57.52%-95.31M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | -102.54%-306.9M | ---- | ---- | ---- | -156.00%-151.53M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 5.31%8.42B | ---- | ---- | ---- | -17.82%8B | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | 5.31%8.42B | ---- | ---- | ---- | -17.82%8B | ---- | ---- |
| Financial expense | ---- | ---- | ---- | -6.10%1.34B | ---- | ---- | ---- | -10.06%1.42B | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 363.52%197.63M | ---- | ---- | ---- | 78.83%-75M | ---- | ---- |
| Special items | ---- | ---- | ---- | -9.55%7.58B | ---- | ---- | ---- | -4.11%8.38B | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 88.75%51.47B | ---- | ---- | ---- | 118.64%27.27B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -202.44%-428.96M | ---- | ---- | ---- | 70.52%-141.83M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | 75.24%-180.26M | ---- | ---- | ---- | -92.97%-727.94M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | -55.72%7.57B | ---- | ---- | ---- | 730.69%17.09B | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | -51.88%-3.01B | ---- | ---- | ---- | -736.55%-1.98B | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 433.90%2.52B | ---- | ---- | ---- | 57.43%-755.54M | ---- | ---- |
| Cash from business operations | ---- | -39.68%15.26B | ---- | 42.19%57.94B | ---- | 32.70%25.29B | ---- | 249.48%40.74B | ---- | 1,087.71%19.06B |
| Other taxs | ---- | -38.74%-353.26M | ---- | -254.34%-789.64M | ---- | -77.29%-254.61M | ---- | 9.87%-222.85M | ---- | -24.72%-143.61M |
| Special items of business | -117.98%-7.24B | ---- | 69.37%10.13B | ---- | 33.71%40.28B | ---- | -25.69%5.98B | ---- | 310.05%30.13B | ---- |
| Net cash from operations | -117.98%-7.24B | -40.47%14.9B | 69.37%10.13B | 41.03%57.15B | 33.71%40.28B | 32.36%25.04B | -25.69%5.98B | 255.10%40.52B | 310.05%30.13B | 1,025.07%18.92B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | 124.44%80.08M | ---- | 228.29%111.95M | ---- | 92.77%35.68M | ---- | -51.13%34.1M | ---- | -62.73%18.51M |
| Loan receivable (increase) decrease | ---- | ---219.16M | ---- | -99.98%184K | ---- | ---- | ---- | 561.21%909.22M | ---- | 12.68%705.03M |
| Sale of fixed assets | ---- | -25.58%213.47M | ---- | 198.00%897.21M | ---- | 129.22%286.85M | ---- | -26.14%301.07M | ---- | 3.57%125.14M |
| Purchase of fixed assets | ---- | 3.75%-5.55B | ---- | -59.89%-11B | ---- | -197.11%-5.77B | ---- | -20.03%-6.88B | ---- | 39.74%-1.94B |
| Sale of subsidiaries | ---- | 5,336.10%736.43M | ---- | 1,747.00%1.66B | ---- | -84.96%13.55M | ---- | 21.07%90.05M | ---- | 304.97%90.05M |
| Recovery of cash from investments | ---- | ---- | ---- | 103.22%233.05B | ---- | ---- | ---- | -36.17%114.68B | ---- | -51.34%55.26B |
| Cash on investment | ---- | 3.08%32.48B | ---- | -60.54%-218.76B | ---- | 147.92%31.51B | ---- | 28.57%-136.26B | ---- | 44.75%-65.75B |
| Other items in the investment business | 200.57%50B | -40.96%1.48B | 48.92%34.75B | 72.19%4.25B | 164.62%16.64B | 164.35%2.5B | 3,050.67%23.34B | 71.45%2.47B | -60.04%-25.74B | 95.00%945.72M |
| Net cash from investment operations | 200.57%50B | 2.23%29.21B | 48.92%34.75B | 141.38%10.21B | 164.62%16.64B | 370.87%28.57B | 3,050.67%23.34B | -67.63%-24.66B | -60.04%-25.74B | -41.65%-10.55B |
| Net cash before financing | -24.88%42.76B | -17.71%44.11B | 53.10%44.88B | 324.72%67.35B | 1,197.62%56.92B | 540.64%53.61B | 303.85%29.32B | 580.24%15.86B | 150.20%4.39B | 188.16%8.37B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -79.11%481.98M | ---- | -52.67%20.26B | ---- | -72.40%2.31B | ---- | 65.64%42.81B | ---- | 16.67%8.36B |
| Refund | ---- | 48.44%-10.72B | ---- | 49.45%-21.49B | ---- | -137.65%-20.79B | ---- | -30.00%-42.51B | ---- | -129.03%-8.75B |
| Issuing shares | ---- | -50.22%12.27M | ---- | -21.42%152.04M | ---- | -78.91%24.64M | ---- | 13.59%193.49M | ---- | 28.68%116.88M |
| Interest paid - financing | ---- | ---- | ---- | 26.12%-427.05M | ---- | ---- | ---- | 50.26%-578.06M | ---- | 43.97%-220.56M |
| Dividends paid - financing | ---- | ---- | ---- | -30.00%-3.19M | ---- | ---- | ---- | ---2.45M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 97.07%-364.84M | ---- | ---26.09B | ---- | ---12.45B | ---- | ---- | ---- | ---- |
| Other items of the financing business | 70.88%-13.79B | -1,181.45%-636.13M | 95.73%-506.47M | 0.70%280.67M | -10,253.01%-47.36B | -78.90%58.82M | -1,997.10%-11.87B | -41.99%278.72M | 132.39%466.5M | -26.74%278.72M |
| Net cash from financing operations | 70.88%-13.79B | 60.42%-12.83B | 95.73%-506.47M | -993.54%-30.41B | -10,253.01%-47.36B | -1,809.81%-32.41B | -1,997.10%-11.87B | 72.16%-2.78B | 132.39%466.5M | -182.47%-1.7B |
| Effect of rate | -32.08%-564.43M | -374.94%-461.6M | -8,530.42%-194.62M | 433.26%556.97M | -411.16%-427.35M | -3.22%167.89M | -120.88%-2.26M | -88.86%104.45M | -85.09%137.34M | -62.04%173.49M |
| Net Cash | 203.11%28.96B | 47.59%31.28B | 154.36%44.38B | 182.47%36.94B | 96.90%9.56B | 217.74%21.2B | 160.66%17.45B | 198.38%13.08B | 147.68%4.85B | 189.74%6.67B |
| Begining period cash | 112.46%70.83B | 112.46%70.83B | 112.46%70.83B | 65.39%33.34B | 65.39%33.34B | 65.39%33.34B | 65.39%33.34B | -38.00%20.16B | -38.00%20.16B | -38.00%20.16B |
| Cash at the end | 133.67%99.23B | 85.83%101.66B | 126.48%115.02B | 112.46%70.83B | 68.87%42.47B | 102.59%54.7B | 89.05%50.78B | 65.39%33.34B | 8.14%25.15B | 5.74%27B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.